We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current TNGX market cap is 578.58M. The company's latest EPS is USD -0.9496 and P/E is -5.42.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 14.6M | 10.73M | 5.43M | 6.47M | 19.88M |
| Operating Income | -23.25M | -25.63M | -35.01M | -42.26M | -29.55M |
| Net Income | -20.71M | -22.26M | -30.76M | -37.91M | -25.55M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 37.04M | 24.86M | 36.53M |
| Operating Income | -181k | -58.19M | -111.07M | -114.17M |
| Net Income | -123k | -58.24M | -108.18M | -101.74M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 379.33M | 428.19M | 402.57M | 406.22M | 381.45M |
| Total Liabilities | 166.38M | 151.59M | 149.46M | 141.77M | 133.78M |
| Total Equity | 212.95M | 276.6M | 253.11M | 264.45M | 247.67M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 168.31M | 500.16M | 436.47M | 402.57M |
| Total Liabilities | 5.95M | 155.41M | 186.99M | 149.46M |
| Total Equity | 5M | 344.75M | 249.48M | 253.11M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -59.38M | -90.52M | -117.98M | -37.86M | -61.46M |
| Investing | 64.24M | 7.57M | 41.43M | -11.2M | 1.5M |
| Financing | 659k | 80.94M | 82.41M | 42.98M | 44.29M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -328k | -59.53M | -109.08M | -117.98M |
| Investing | -166.75M | -183.43M | 26.4M | 41.43M |
| Financing | 168.39M | 357.33M | 1.62M | 82.41M |
| Market Cap | 578.58M |
| Price to Earnings Ratio | -5.42 |
| Price to Sales Ratio | 15.11 |
| Price to Cash Ratio | 8.31 |
| Price to Book Ratio | 2.18 |
| Dividend Yield | - |
| Shares Outstanding | 107.14M |
| Average Volume (1 week) | 1.19M |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | -34.62% |
| 52 Week High | 13.005 |
| 52 Week Low | 5.15 |
| Spread (Intraday) | 0.96 (16.11%) |
| Company Name | Tango Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.tangotx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
